Pharma Journalist -

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide license agreement with Menlo Park, California-based xCella Biosciences, Inc. Under the license, xCella will…
Read More...

New research conducted by scientists at the University of Sheffield into a drug candidate which could help to delay the onset of motor neurone disease has shown encouraging early…
Read More...

AstraZeneca announced that, effective 1 June 2017, the Board has appointed Professor Nazneen Rahman as a Non-Executive Director of AstraZeneca PLC. On appointment, Professor Rahman also…
Read More...

TaiGen Biotechnology has submitted a New Drug Application (NDA) for Taigexyn (Nemonoxacin)intravenous formulation to China Food and Drug Administration (CFDA). Taigexyn is a novel…
Read More...

BioPharma Services has successfully completed 3 inspections this month by the US FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri. Over…
Read More...

Bluebee and MediSapiens enters a partnership to provide customers with tailored end-to-end analytical solutions for Next Generation Sequencing (NGS) data. Sequencing technology is…
Read More...

Compugen Ltd board of directors has appointed Michal Preminger (PhD, MBA, Executive Director at Harvard University Office of Technology Development's Harvard Medical School site) as…
Read More...

Recipharm has appointed  Shabbir Mostafa as Director, Business Management UK & Ireland with responsibility for supporting customers in the UK & Ireland and to driving up sales.…
Read More...

Avista Pharma Solutions announced that Minneapolis Medical Research Foundation (MMRF) has selected Avista Pharma to manufacture an opioid-derived small molecule. The research is funded…
Read More...

Hovione announced that it will soon initiate recruitment for its Phase 1 clinical trial of HY02. This first in human study is a double-blinded, randomized trial, which will include…
Read More...